Skip to main content
. 2012 Mar 15;40(13):6223–6234. doi: 10.1093/nar/gks239

Figure 3.

Figure 3.

Il4R-α siRNA activity is also independent of Ago 1, 3, and 4. Wild-type and Ago2−/− MEFs were treated with ASOs targeting Ago1, Ago3, or Ago4. The following day Ago-reduced cells were seeded in 96-well plates then transfected with PTEN or Il4R-α siRNA at concentrations ranging from 300 pM to 300 nM. Messenger RNA reduction was measured after 24 h by qRT/PCR. IC50 curves are plotted versus no siRNA control for each treatment condition. (A) Activity of PTEN siRNA 341391 in wild-type (WT) and Ago2−/− (KO) cells. (B) Activity of Il4R-α siRNA 383281 in WT and KO MEF cells. (C) Activity of PTEN siRNA 341391 in KO cells (circle), and KO cells reduced in Ago 1 (inverted triangle), Ago 3 (filled circle), or Ago 4 (filled triangle). (D) Activity of Il4R-α siRNA 383281 in KO cells (circle), and KO cells reduced in Ago 1 (inverted triangle), Ago 3 (filled circle), or Ago 4 (filled triangle).